A Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma

Summary

The goal of this observational study is to select contents and tools for the future development of a web app aiming to support patients' navigation for empowering decision-making through a higher awareness of urothelial carcinoma and its treatments, improving also educational aspects. The main question it aims to answer is: What are the contents that patients diagnosed with urothelial carcinoma find useful to include in a web app to streamline their quality of life assessment and monitoring? Participants candidate for systemic treatments, or already under treatment, will answer questionnaires about the tools to include in a web app designed for urothelial carcinoma.

Eligibility

Inclusion Criteria:

* histological diagnosis of urothelial carcinoma;
* ≥ 18 years old,
* candidate for systemic treatment with chemotherapy, immune-checkpoint inhibitors, antibody-drug conjugates, or target therapy (patients can be enrolled also if the treatment has started),
* possession of a mobile device (e.g., smartphone or personal computer) with the physical and psychological ability to use mobile devices,
* understanding and speaking the Italian language,
* ability to sign an informed consent.

Exclusion Criteria:

* not possession of a mobile device,
* unwillingness to give informed consent.

Conditions2

Browse More Trials